Klein Hersh Blog

The New Workplace—Envisioning a Return to the Office Post-Pandemic

Across the US and around the world, companies large and small are grappling with what a return to the office looks like in the aftermath of a global pandemic. What will change? What will remain the same? What are the challenges that lie ahead? And what are the opportunities? Clearly, we’re far from out of the woods regarding the prevalence ...
September 14, 2021

The Domino Effect and Why it Fuels Us Every Day

I’ve always loved science. I chose biology as my college major and had every intention of continuing on to medical school. But once I fully understood the years of education required to become a doctor, I changed course, and chose to become an attorney. I attended Drexel Law School on a partial scholarship, conquered the LSAT, and joined a prestigious ...
June 30, 2021

The Real Meaning of DEI and Why Companies Need to Unleash Its Power

These days, everyone is talking about diversity, equity and inclusion (DEI). Recent events have led to long overdue realizations about the injustices that persist in society, and our individual and collective responsibility to do better. This has always mattered to me deeply in both my professional and personal life. I’m proud to say that at Klein Hersh, the importance―and intrinsic ...
May 19, 2021

Innovation and Investment in Mental Health is Paying Dividends for Patients and Purveyors

For centuries, the stigma surrounding mental and behavioral health created an enormous barrier that prevented people from seeking treatment. Many were afraid to admit they were struggling, and painfully uncomfortable discussing their concerns with loved ones. But in March of 2020, everything changed. The coronavirus pandemic affected each of us in different ways, but one thing was certain. It became ...
April 13, 2021

Reflections on 2020 and an Optimistic Outlook for the Year Ahead

By Jesse Klein, Jason Hersh, and Josh Albert We’ve just reached the end of a year unlike any other. As we look back on challenges faced and what has been accomplished over the last 12 months, there are many things to take with us into 2021. We continued to be amazed by the pace of scientific discovery.  The value of ...
January 28, 2021

The Cell and Gene Therapy Revolution

A conversation with Klein Hersh’s Hillary Kaplan Even as the global biopharma industry urgently focuses on combatting COVID-19, the cell/gene therapy sector marches onward, experiencing strong growth and expansion. The sector has continued its rapid progression into one of the industry’s hottest markets, spurred on by robust venture capital investment in new company formation and ongoing strategic acquisitions by big ...
September 24, 2020

Common Questions in the Search Process: Advice for Candidates

In helping organizations across the healthcare industry build their analytics and data science teams, I’ve had the opportunity to connect with thousands of job candidates. During these countless conversations, I’ve come across some tough, but common questions that many candidates have, but are unsure how to address with prospective employers. Here are answers to five commonly asked questions that candidates ...
September 10, 2020

The Skyrocketing Growth of Telehealth: The Healthcare Sector Adapts to Change Amid COVID-19

There is no doubt that we are all living history as we face the COVID-19 pandemic. And while every industry has been impacted by this enormous global challenge, there are some, particularly those surrounding healthcare and technology, that are experiencing record surge due to significant need. Telehealth and virtual care have been brewing in the background for years, but the ...
July 8, 2020

Changing Role of the Quality Professional in Pharma’s New Era

Drug discovery and manufacturing is rapidly changing across the pharmaceutical industry. The increased focus on rare diseases, along with breakthroughs in biologics, gene and cell therapy, and other forms of personalized medicine, have empowered bold innovation among drug developers. Many companies are leveraging these scientific advancements to pursue a new aspirational focus on finding cures for the most-difficult-to-treat diseases. As ...
January 18, 2020

Meeting the Growing Talent Demand in Cell and Gene Therapy & Biologics

Boom in cell and gene therapy Among these segments is cell and gene therapy, where innovative science in areas such as cardiovascular disease, cancer, and genetic disorders is driving rapid R&D activity to address critical unmet patient needs. Recent scientific successes in cell and gene therapy are fostering robust venture investment in start-ups, as well as a flurry of mergers ...
October 1, 2019